247 related articles for article (PubMed ID: 32118000)
21. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
[TBL] [Abstract][Full Text] [Related]
22. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of metabolic parameters measured by
Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW
J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157
[TBL] [Abstract][Full Text] [Related]
24. Thoracic staging with
Schaarschmidt BM; Grueneisen J; Metzenmacher M; Gomez B; Gauler T; Roesel C; Heusch P; Ruhlmann V; Umutlu L; Antoch G; Buchbender C
Eur Radiol; 2017 Feb; 27(2):681-688. PubMed ID: 27180186
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of
Lee JW; Choi JS; Lyu J; Lee SM
Lung Cancer; 2018 Apr; 118():41-47. PubMed ID: 29572001
[TBL] [Abstract][Full Text] [Related]
26. Triage of Limited Versus Extensive Disease on
Saima R; Humayun B; Khalid NI
Asia Ocean J Nucl Med Biol; 2017; 5(2):109-113. PubMed ID: 28660221
[TBL] [Abstract][Full Text] [Related]
27. Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET).
Kut V; Spies W; Spies S; Gooding W; Argiris A
Am J Clin Oncol; 2007 Feb; 30(1):45-50. PubMed ID: 17278894
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
Xiao Y; Wang L; Jiang X; She W; He L; Hu G
Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Performance of
Ballova V; Muoio B; Albano D; Bertagna F; Canziani L; Ghielmini M; Ceriani L; Treglia G
Diagnostics (Basel); 2020 Feb; 10(2):. PubMed ID: 32059610
[TBL] [Abstract][Full Text] [Related]
30. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
31. The Role of 18F-FDG PET/CT on Staging and Prognosis in Patients with Small Cell Lung Cancer.
Zer A; Domachevsky L; Rapson Y; Nidam M; Flex D; Allen AM; Stemmer SM; Groshar D; Bernstine H
Eur Radiol; 2016 Sep; 26(9):3155-61. PubMed ID: 26685851
[TBL] [Abstract][Full Text] [Related]
32. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.
Quartuccio N; Salem A; Laudicella R; Spataro A; Chiaravalloti A; Caobelli F; Cistaro A; Alongi P; Evangelista L
Nucl Med Commun; 2021 Aug; 42(8):839-845. PubMed ID: 33741854
[TBL] [Abstract][Full Text] [Related]
33. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Kim SJ; Lee SW
J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
[TBL] [Abstract][Full Text] [Related]
34. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study.
Chin R; McCain TW; Miller AA; Dunagan DP; Acostamadiedo J; Douglas Case L; Harkness BA; Adler LP; Haponik EF
Lung Cancer; 2002 Jul; 37(1):1-6. PubMed ID: 12057859
[TBL] [Abstract][Full Text] [Related]
35. The Contribution of Fluorine
Budak E; Çok G; Akgün A
Mol Imaging Radionucl Ther; 2018 Jun; 27(2):73-80. PubMed ID: 29889029
[TBL] [Abstract][Full Text] [Related]
36. Prospective comparison of
Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073
[TBL] [Abstract][Full Text] [Related]
37. PET-CT guided curative conformal radiation therapy in limited stage small cell lung cancer.
Ulger S; Demirci NY; Aydinkarahaliloglu E; Kahraman FC; Ozmen O; Erdogan Y; Cetin E; Avci E; Cengiz M
J Thorac Dis; 2015 Mar; 7(3):295-302. PubMed ID: 25922706
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of
Kamani CH; Allenbach G; Jreige M; Pavon AG; Meyer M; Testart N; Firsova M; Fernandes Vieira V; Boughdad S; Nicod Lalonde M; Schaefer N; Guery B; Monney P; Prior JO; Treglia G
Diagnostics (Basel); 2020 Sep; 10(10):. PubMed ID: 32993032
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis.
Annunziata S; Pizzuto DA; Caldarella C; Galiandro F; Sadeghi R; Treglia G
World J Gastroenterol; 2015 Oct; 21(40):11481-8. PubMed ID: 26523112
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Performance of ¹⁸F-FDG PET and PET/CT for the Detection of Recurrent Esophageal Cancer After Treatment with Curative Intent: A Systematic Review and Meta-Analysis.
Goense L; van Rossum PS; Reitsma JB; Lam MG; Meijer GJ; van Vulpen M; Ruurda JP; van Hillegersberg R
J Nucl Med; 2015 Jul; 56(7):995-1002. PubMed ID: 25952733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
